6/7/2016
NeonatalJaundiceClinicalPresentation:History,PhysicalExamination
NeonatalJaundiceClinicalPresentation
Author:ThorWRHansen,MD,PhD,MHA,FAAPChiefEditor:TedRosenkrantz,MDmore...
Updated:Mar04,2016
History
Presentationanddurationofneonataljaundice
Notethefollowing:
Typically,neonataljaundicepresentsonthesecondorthirddayoflife.
Jaundicethatisvisibleduringthefirst24hoursoflifeislikelytobe
nonphysiologicfurtherevaluationissuggested.
Infantswhopresentwithjaundiceafter34daysoflifemayalsorequire
closerscrutinyandmonitoring.
Ininfantswithseverejaundiceorjaundicethatcontinuesbeyondthefirst12
weeksoflife,theresultsofthenewbornmetabolicscreenshouldbechecked
forgalactosemiaandcongenitalhypothyroidism,furtherfamilyhistoryshould
beexplored(seebelow),theinfant'sweightcurveshouldbeevaluated,the
mother'simpressionsasfarasadequacyofbreastfeedingshouldbeelicited,
andthestoolcolorshouldbeassessed.
Familyhistory
Obtainthefollowinginformation:
Previoussiblingwithjaundiceintheneonatalperiod,particularlyifthe
jaundicerequiredtreatment
OtherfamilymemberswithjaundiceorknownfamilyhistoryofGilbert
syndrome
Anemia,splenectomy,orbilestonesinfamilymembersorknownheredity
forhemolyticdisorders
Liverdiseaseinfamilymembers
Historyofpregnancyanddelivery
Ascertainthefollowinginformation:
Maternalillnesssuggestiveofviralorotherinfection
Maternaldrugintake,includingtheuseofherbalremedies
Delayedcordclamping
Birthtraumawithbruisingand/orfractures.
Postnatalhistory
Obtaindetailsofthefollowing:
Lossofstoolcolor
Breastfeeding
Useofdrugsandherbalremediesinthelactatingmother
Greaterthanaverageweightloss
Symptomsorsignsofhypothyroidism
Symptomsorsignsofmetabolicdisease(eg,galactosemia)
Exposuretototalparentalnutrition
PhysicalExamination
Neonataljaundicefirstbecomesvisibleinthefaceandforehead.Identificationis
aidedbypressureontheskin,sinceblanchingrevealstheunderlyingcolor.Jaundice
thengraduallybecomesvisibleonthetrunkandextremities.Thiscephalocaudal
progressioniswelldescribed,evenin19thcenturymedicaltexts.Jaundice
disappearsintheoppositedirection.Theexplanationforthisphenomenonisnot
wellunderstood,butbothchangesinbilirubinalbuminbindingrelatedtopHand
differencesinskintemperatureandbloodflowhavebeenproposed. [22,23]This
phenomenonisclaimedtobeclinicallyusefulbecause,independentofother
factors,visiblejaundiceinthelowerextremitiesstronglysuggeststheneedtocheck
thebilirubinlevel,eitherintheserumornoninvasivelyviatranscutaneous
bilirubinometry.
Recentworkintheauthorsgroup(Tllfsrudetal,unpublisheddata)wasnotable
toconfirmthissocalledcephalocaudalprogressionofjaundice.Thus,whendermal
jaundicewasmeasurednoninvasivelyontheforehead,sternum,andsymphysis,no
cephalocaudaltrendwasevident.
Inmostinfants,yellowcoloristheonlyfindingonphysicalexamination.More
intensejaundicemaybeassociatedwithdrowsiness.Brainstemauditoryevoked
potentialsperformedatthistimemayrevealprolongationoflatencies,decreased
amplitudes,orboth.
Overtneurologicfindings,suchaschangesinmuscletone,seizures,oralteredcry
characteristics,inasignificantlyjaundicedinfantaredangersignsandrequire
immediateattentiontopreventkernicterus.Inthepresenceofsuchsymptomsor
signs,effectivephototherapyshouldcommenceimmediatelywithoutwaitingforthe
laboratorytestresults(seeLaboratoryStudies).Thepotentialneedforexchange
transfusionshouldnotprecludetheimmediateinitiationofphototherapy. [24,25]
http://emedicine.medscape.com/article/974786clinical
1/5
6/7/2016
NeonatalJaundiceClinicalPresentation:History,PhysicalExamination
Hepatosplenomegaly,petechiae,andmicrocephalymaybeassociated
withhemolyticanemia,sepsis,andcongenitalinfectionsandshouldtriggera
diagnosticevaluationdirectedtowardsthesediagnoses.Neonataljaundicemaybe
exacerbatedinthesesituations.
DifferentialDiagnoses
ContributorInformationandDisclosures
Author
ThorWRHansen,MD,PhD,MHA,FAAPProfessor,DepartmentofNeonatology,WomenandChildren's
Division,DirectorofClinicalEthics,OsloUniversityHospitalHC,Rikshospitalet,DirectorofPediatricEducation,
FacultyofMedicine,UniversityofOslo,Norway
ThorWRHansen,MD,PhD,MHA,FAAPisamemberofthefollowingmedicalsocieties:AmericanAcademyof
Pediatrics,AmericanPediatricSociety,SocietyforPediatricResearch,EuropeanSocietyforPaediatric
Research,PerinatalResearchSociety,AmericanAssociationfortheHistoryofMedicine,NewYorkAcademyof
Sciences
Disclosure:Nothingtodisclose.
SpecialtyEditorBoard
MaryLWindle,PharmDAdjunctAssociateProfessor,UniversityofNebraskaMedicalCenterCollegeof
PharmacyEditorinChief,MedscapeDrugReference
Disclosure:Nothingtodisclose.
BrianSCarter,MD,FAAPProfessorofPediatrics,UniversityofMissouriKansasCitySchoolofMedicine
AttendingPhysician,DivisionofNeonatology,Children'sMercyHospitalandClinicsFaculty,Children'sMercy
BioethicsCenter
BrianSCarter,MD,FAAPisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,American
AcademyofHospiceandPalliativeMedicine,AmericanAcademyofPediatrics,AmericanPediatricSociety,
AmericanSocietyforBioethicsandHumanities,AmericanSocietyofLaw,Medicine&Ethics,Societyfor
PediatricResearch,NationalHospiceandPalliativeCareOrganization
Disclosure:Nothingtodisclose.
ChiefEditor
TedRosenkrantz,MDProfessor,DepartmentsofPediatricsandObstetrics/Gynecology,DivisionofNeonatal
PerinatalMedicine,UniversityofConnecticutSchoolofMedicine
TedRosenkrantz,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofPediatrics,
AmericanPediatricSociety,EasternSocietyforPediatricResearch,AmericanMedicalAssociation,Connecticut
StateMedicalSociety,SocietyforPediatricResearch
Disclosure:Nothingtodisclose.
AdditionalContributors
OussamaItani,MD,FAAP,FACNClinicalAssociateProfessorofPediatricsandHumanDevelopment,Michigan
StateUniversityMedicalDirector,DepartmentofNeonatology,BorgessMedicalCenter
OussamaItani,MD,FAAP,FACNisamemberofthefollowingmedicalsocieties:AmericanAcademyof
Pediatrics,AmericanAssociationforPhysicianLeadership,AmericanHeartAssociation,AmericanCollegeof
Nutrition
Disclosure:Nothingtodisclose.
References
1.HuangMJ,KuaKE,TengHC,TangKS,WengHW,HuangCS.Riskfactorsforseverehyperbilirubinemia
inneonates.PediatrRes.2004Nov.56(5):6829.[Medline].
2.ChristensenRD,YaishHM.Hemolyticdisorderscausingsevereneonatalhyperbilirubinemia.ClinPerinatol.
2015Sep.42(3):51527.[Medline].
3.WoodgateP,JardineLA.Neonataljaundice:phototherapy.BMJClinEvid.2015May22.2015:[Medline].
4.MaciasRI,MarinJJ,SerranoMA.Excretionofbiliarycompoundsduringintrauterinelife.WorldJ
Gastroenterol.2009Feb21.15(7):81728.[Medline].[FullText].
5.YusoffS,VanRostenbergheH,YusoffNM,etal.FrequenciesofA(TA)7TAA,G71R,andG493R
mutationsoftheUGT1A1geneintheMalaysianpopulation.BiolNeonate.2006.89(3):1716.[Medline].
[FullText].
6.MemonN,WeinbergerBI,HegyiT,AleksunesLM.Inheriteddisordersofbilirubinclearance.PediatrRes.
2015Nov23.[Medline].
7.WatchkoJF,LinZ.Geneticsofneonataljaundice.StevensonDK,MaiselsMJ,WatchkoJF.Careofthe
jaundicedneonate.NewYork:McGrawHill2012.127.
8.FujiwaraR,MaruoY,ChenS,TukeyRH.RoleofextrahepaticUDPglucuronosyltransferase1A1:
Advancesinunderstandingbreastmilkinducedneonatalhyperbilirubinemia.ToxicolApplPharmacol.2015
Nov15.289(1):12432.[Medline].
9.HuaL,ShiD,BishopPR,GoscheJ,MayWL,NowickiMJ.TheroleofUGT1A1*28mutationinjaundiced
infantswithhypertrophicpyloricstenosis.PediatrRes.2005Nov.58(5):8814.[Medline].
10.YamamotoA,NishioH,WakuS,YokoyamaN,YonetaniM,UetaniY.Gly71Argmutationofthebilirubin
UDPglucuronosyltransferase1A1geneisassociatedwithneonatalhyperbilirubinemiaintheJapanese
population.KobeJMedSci.2002Aug.48(34):737.[Medline].
11.KumralA,OzkanH,DumanN,YesilirmakDC,IslekelH,OzalpY.Breastmilkjaundicecorrelateswithhigh
levelsofepidermalgrowthfactor.PediatrRes.2009Aug.66(2):21821.[Medline].
12.MaiselsMJ,NewmanTB.Theepidemiologyofneonatalhyperbilirubinemia.StevensonDK,MaiselsMJ,
WatchkoJF.Careofthejaundicedneonate.NewYork:McGrawHill2012.97113.
http://emedicine.medscape.com/article/974786clinical
2/5
6/7/2016
NeonatalJaundiceClinicalPresentation:History,PhysicalExamination
13.MaiselsMJ,GiffordK.Normalserumbilirubinlevelsinthenewbornandtheeffectofbreastfeeding.
Pediatrics.1986Nov.78(5):83743.[Medline].
14.[Guideline]AtkinsonLR,EscobarGJ,TakyamaJI,NewmanTB.Phototherapyuseinjaundicednewborns
inalargemanagedcareorganization:docliniciansadheretotheguideline?.Pediatrics.2003.111:e555.
[Medline].[FullText].
15.SlusherTM,OlusaniyaBO.Neonataljaundiceinlowandmiddleincomecountries.StevensonDK,
MaiselsMJ,WatchkoJF.Careofthejaundicedneonate.NewYork:McGrawHill2012.26373.
16.MooreLG,NewberryMA,FreebyGM,CrnicLS.Increasedincidenceofneonatalhyperbilirubinemiaat
3,100minColorado.AmJDisChild.1984Feb.138(2):15761.[Medline].
17.SariciSU,SerdarMA,KorkmazA,etal.Incidence,course,andpredictionofhyperbilirubinemiainnear
termandtermnewborns.Pediatrics.2004.113:77580.[Medline].[FullText].
18.EbbesenF,AnderssonC,VerderH,GrytterC,PedersenBjergaardL,PetersenJR.Extreme
hyperbilirubinaemiaintermandnearterminfantsinDenmark.ActaPaediatr.2005Jan.94(1):5964.
[Medline].
19.LinnS,SchoenbaumSC,MonsonRR,RosnerB,StubblefieldPG,RyanKJ.Epidemiologyofneonatal
hyperbilirubinemia.Pediatrics.1985Apr.75(4):7704.[Medline].
20.MaiselsMJ,NewmanTB.Prevention,screeningandpostnatalmanagementofneonatal
hyperbilirubinemia.StevensonDK,MaiselsMJ,WatchkoJF.Careofthejaundicedneonate.NewYork:
McGrawHill2012.17594.
21.SlusherTM,VremanHJ,McLarenDW,LewisonLJ,BrownAK,StevensonDK.Glucose6phosphate
dehydrogenasedeficiencyandcarboxyhemoglobinconcentrationsassociatedwithbilirubinrelatedmorbidity
anddeathinNigerianinfants.JPediatr.1995Jan.126(1):1028.[Medline].
22.KnudsenA.TheinfluenceofthereservealbuminconcentrationandpHonthecephalocaudalprogression
ofjaundiceinnewborns.EarlyHumDev.1991JanFeb.25(1):3741.[Medline].
23.PurcellN,BeebyPJ.Theinfluenceofskintemperatureandskinperfusiononthecephalocaudal
progressionofjaundiceinnewborns.JPaediatrChildHealth.2009Oct.45(10):5826.[Medline].
24.[Guideline]BhutaniVK,MaiselsMJ,StarkAR,BuonocoreG.Managementofjaundiceandpreventionof
severeneonatalhyperbilirubinemiaininfants>or=35weeksgestation.Neonatology.2008.94(1):637.
[Medline].
25.BhutaniVK,JohnsonLH,MaiselsMJ,etal.Kernicterus:epidemiologicalstrategiesforitsprevention
throughsystemsbasedapproaches.JPerinatol.2004.24:65062.[Medline].[FullText].
26.MishraS,ChawlaD,AgarwalR,DeorariAK,PaulVK,BhutaniVK.Transcutaneousbilirubinometry
reducestheneedforbloodsamplinginneonateswithvisiblejaundice.ActaPaediatr.2009Dec.
98(12):19169.[Medline].
27.BhutaniVK,GourleyGR,AdlerS,etal.Noninvasivemeasurementoftotalserumbilirubininamultiracial
predischargenewbornpopulationtoassesstheriskofseverehyperbilirubinemia.Pediatrics.2000Aug.
106(2):E17.[Medline].[FullText].
28.KerenR,TremontK,LuanX,CnaanA.Visualassessmentofjaundiceintermandlatepreterminfants.
ArchDisChildFetalNeonatalEd.2009Sep.94(5):F31722.[Medline].
29.RiskinA,TamirA,KugelmanA,HemoM,BaderD.Isvisualassessmentofjaundicereliableasa
screeningtooltodetectsignificantneonatalhyperbilirubinemia?.JPediatr.2008Jun.152(6):7827,
787.e12.[Medline].
30.SchutzmanDL,SekhonR,HundalaniS.HourspecificbilirubinnomogramininfantswithABO
incompatibilityanddirectCoombspositiveresults.ArchPediatrAdolescMed.2010Dec.164(12):115864.
[Medline].
31.AhlforsCE,ParkerAE.Unboundbilirubinconcentrationisassociatedwithabnormalautomatedauditory
brainstemresponseforjaundicednewborns.Pediatrics.2008May.121(5):9768.[Medline].
32.MreihilK,MadsenP,NakstadB,BenthJS,EbbesenF,HansenTW.Earlyformationofbilirubinisomers
duringphototherapyforneonataljaundice:effectsofsinglevs.doublefluorescentlampsvs.photodiodes.
PediatrRes.2015Jul.78(1):5662.[Medline].
33.VandborgPK,HansenBM,GreisenG,EbbesenF.Doseresponserelationshipofphototherapyfor
hyperbilirubinemia.Pediatrics.2012Aug.130(2):e3527.[Medline].
34.KumarP,ChawlaD,DeorariA.Lightemittingdiodephototherapyforunconjugatedhyperbilirubinaemiain
neonates.CochraneDatabaseSystRev.2011Dec7.12:CD007969.[Medline].
35.TridenteA,DeLucaD.Efficacyoflightemittingdiodeversusotherlightsourcesfortreatmentofneonatal
hyperbilirubinemia:asystematicreviewandmetaanalysis.ActaPaediatr.2012May.101(5):45865.
[Medline].
36.GottsteinR,CookeRW.Systematicreviewofintravenousimmunoglobulininhaemolyticdiseaseofthe
newborn.ArchDisChildFetalNeonatalEd.2003Jan.88(1):F610.[Medline].[FullText].
37.RuboJ,AlbrechtK,LaschP,etal.Highdoseintravenousimmuneglobulintherapyforhyperbilirubinemia
causedbyRhhemolyticdisease.JPediatr.1992Jul.121(1):937.[Medline].
38.HuizingK,RoislienJ,HansenT.Intravenousimmuneglobulinreducestheneedforexchangetransfusions
inRhesusandAB0incompatibility.ActaPaediatr.2008Oct.97(10):13625.[Medline].
39.HansenTW.Therapeuticapproachestoneonataljaundice:aninternationalsurvey.ClinPediatr(Phila).
1996Jun.35(6):30916.[Medline].
40.[Guideline]AmericanAcademyofPediatricsSubcommitteeonHyperbilirubinemia.Managementof
hyperbilirubinemiainthenewborninfant35ormoreweeksofgestation.Pediatrics.2004Jul.114(1):297
316.[Medline].[FullText].
41.MaiselsMJ,WatchkoJF,BhutaniVK,StevensonDK.Anapproachtothemanagementof
hyperbilirubinemiainthepreterminfantlessthan35weeksofgestation.JPerinatol.2012Sep.32(9):660
4.[Medline].
http://emedicine.medscape.com/article/974786clinical
3/5
6/7/2016
NeonatalJaundiceClinicalPresentation:History,PhysicalExamination
42.MorrisBH,OhW,TysonJE,etal.Aggressivevs.conservativephototherapyforinfantswithextremelylow
birthweight.NEnglJMed.2008Oct30.359(18):188596.[Medline].[FullText].
43.HintzSR,StevensonDK,YaoQ,etal.Isphototherapyexposureassociatedwithbetterorworseoutcomes
in501to1000gbirthweightinfants?.ActaPaediatr.2011Jul.100(7):960965.[Medline].
44.TysonJE,PedrozaC,LangerJ,etal.Doesaggressivephototherapyincreasemortalitywhiledecreasing
profoundimpairmentamongthesmallestandsickestnewborns?.JPerinatol.2012Sep.32(9):67784.
[Medline].[FullText].
45.HansenTW.Lettherebelightbutshouldtherebeless?.JPerinatol.2012Sep.32(9):64951.[Medline].
46.MadanJC,KendrickD,HagadornJI,FrantzID3rd.Patentductusarteriosustherapy:impactonneonatal
and18monthoutcome.Pediatrics.2009Feb.123(2):67481.[Medline].
47.JohnsonL,BhutaniVK,KarpK,SivieriEM,ShapiroSM.ClinicalreportfromthepilotUSAKernicterus
Registry(1992to2004).JPerinatol.2009Feb.29Suppl1:S2545.[Medline].
48.HansenTW,NietschL,NormanE,etal.Reversibilityofacuteintermediatephasebilirubinencephalopathy.
ActaPaediatr.2009Oct.98(10):168994.[Medline].
49.CaladoCS,PereiraAG,SantosVN,CastroMJ,MaioJF.Whatbringsnewbornstotheemergency
department?:a1yearstudy.PediatrEmergCare.2009Apr.25(4):2448.[Medline].
50.NewmanTB,LiljestrandP,EscobarGJ.Combiningclinicalriskfactorswithserumbilirubinlevelstopredict
hyperbilirubinemiainnewborns.ArchPediatrAdolescMed.2005Feb.159(2):1139.[Medline].
51.BhutaniVK,JohnsonLH,KerenR.Diagnosisandmanagementofhyperbilirubinemiainthetermneonate:
forasaferfirstweek.PediatrClinNorthAm.2004Aug.51(4):84361,vii.[Medline].
52.EggertLD,WiedmeierSE,WilsonJ,ChristensenRD.Theeffectofinstitutingaprehospitaldischarge
newbornbilirubinscreeningprograminan18hospitalhealthsystem.Pediatrics.2006May.117(5):e855
62.[Medline].
53.PaulIM,PhillipsTA,WidomeMD,HollenbeakCS.Costeffectivenessofpostnatalhomenursingvisitsfor
preventionofhospitalcareforjaundiceanddehydration.Pediatrics.2004Oct.114(4):101522.[Medline].
54.SureshGK,ClarkRE.Costeffectivenessofstrategiesthatareintendedtopreventkernicterusinnewborn
infants.Pediatrics.2004Oct.114(4):91724.[Medline].
55.[Guideline]MaiselsMJ,BhutaniVK,BogenD,NewmanTB,StarkAR,WatchkoJF.Hyperbilirubinemiain
thenewborninfant>or=35weeks'gestation:anupdatewithclarifications.Pediatrics.2009Oct.
124(4):11938.[Medline].
56.BuiterHD,DijkstraSS,OudeElferinkRF,BijsterP,WoltilHA,VerkadeHJ.Neonataljaundiceandstool
productioninbreastorformulafedterminfants.EurJPediatr.2008May.167(5):5017.[Medline].
57.CremerRJ,PerrymanPW.Influenceoflightonthehyperbilirubinemiaofinfants.Lancet.1958.1:10947.
58.GourleyGR,LiZ,KreamerBL,KosorokMR.Acontrolled,randomized,doubleblindtrialofprophylaxis
againstjaundiceamongbreastfednewborns.Pediatrics.2005Aug.116(2):38591.[Medline].[FullText].
59.GrohmannK,RoserM,RolinskiB,etal.Bilirubinmeasurementforneonates:comparisonof9frequently
usedmethods.Pediatrics.2006Apr.117(4):117483.[Medline].
60.HansenTW.Acutemanagementofextremeneonataljaundicethepotentialbenefitsofintensified
phototherapyandinterruptionofenterohepaticbilirubincirculation.ActaPaediatr.1997Aug.86(8):8436.
[Medline].
61.HansenTW.Recentadvancesinthepharmacotherapyforhyperbilirubinaemiaintheneonate.ExpertOpin
Pharmacother.2003.4(11):193948.[Medline].[FullText].
62.HansenTW,AllenJW.Hemolyticanemiadoesnotincreaseentryinto,noralterrateofclearanceof
bilirubinfromratbrain.BiolNeonate.1996.69(4):26874.[Medline].
63.HartC,CameronR.Theimportanceofirradianceandareainneonatalphototherapy.ArchDisChildFetal
NeonatalEd.2005.90:F437F440.[Medline].[FullText].
64.Hervieux,J.Del'icteredesnouveaunes.Paris:Thesemed.1847.
65.HoHT,NgTK,TsuiKC,LoYC.EvaluationofanewtranscutaneousbilirubinometerinChinesenewborns.
ArchDisChildFetalNeonatalEd.2006Nov.91(6):F4348.[Medline].
66.KaplanM,BromikerR,SchimmelMS,AlgurN,HammermanC.Evaluationofdischargemanagementin
thepredictionofhyperbilirubinemia:theJerusalemexperience.JPediatr.2007Apr.150(4):4127.
[Medline].
67.KaplanM,RenbaumP,VremanHJ,WongRJ,LevyLahadE,HammermanC.(TA)nUGT1A1Promoter
Polymorphism:ACrucialFactorinthePathophysiologyofJaundiceinG6PDDeficientNeonates.Pediatr
Res.2007Apr5.[Medline].
68.KaplanM,ShchorsI,AlgurN,BromikerR,SchimmelMS,HammermanC.Visualscreeningversus
transcutaneousbilirubinometryforpredischargejaundiceassessment.ActaPaediatr.2008Jun.97(6):759
63.[Medline].
69.KerenR,BhutaniVK,LuanX,NihtianovaS,CnaanA,SchwartzJS.Identifyingnewbornsatriskof
significanthyperbilirubinaemia:acomparisonoftworecommendedapproaches.ArchDisChild.2005Apr.
90(4):41521.[Medline].
70.KuzniewiczMW,EscobarGJ,WiS,LiljestrandP,McCullochC,NewmanTB.Riskfactorsforsevere
hyperbilirubinemiaamonginfantswithborderlinebilirubinlevels:anestedcasecontrolstudy.JPediatr.
2008Aug.153(2):23440.[Medline].
71.LinZ,FontaineJ,WatchkoJF.Coexpressionofgenepolymorphismsinvolvedinbilirubinproductionand
metabolism.Pediatrics.2008Jul.122(1):e15662.[Medline].
72.MaiselsMJ,McDonaghAF.Phototherapyforneonataljaundice.NEnglJMed.2008Feb28.358(9):9208.
[Medline].
73.MaiselsMJ,NewmanTB,WatchkoJF.Effectofpredischargebilirubinscreeningonsubsequent
hyperbilirubinemia.Pediatrics.2006Oct.118(4):1796authorreply19767.[Medline].
http://emedicine.medscape.com/article/974786clinical
4/5
6/7/2016
NeonatalJaundiceClinicalPresentation:History,PhysicalExamination
74.MusluN,DogruerZN,EskandariG,AticiA,KulS,AtikU.AreglutathioneStransferasegene
polymorphismslinkedtoneonataljaundice?.EurJPediatr.2008Jan.167(1):5761.[Medline].
75.NewmanTB,LiljestrandP,JeremyRJ,FerrieroDM,WuYW,HudesES.Outcomesamongnewbornswith
totalserumbilirubinlevelsof25mgperdeciliterormore.NEnglJMed.2006May4.354(18):1889900.
[Medline].
76.OstrowJD,JandlJH,SchmidR.Theformationofbilirubinfromhemoglobininvivo.JClinInvest.1962.
41:162837.
77.SeidmanDS,MoiseJ,ErgazZ.Anewbluelightemittingphototherapydevice:aprospectiverandomized
controlledstudy.JPediatr.2000.136:7714.[Medline].[FullText].
78.SmithermanH,StarkAR,BhutanVK.Earlyrecognitionofneonatalhyperbilirubinemiaanditsemergent
management.SeminFetalNeonatalMed.2006Jun.11(3):21424.[Medline].
79.SunG,WuM,CaoJ,DuL.CordbloodbilirubinlevelinrelationtobilirubinUDPglucuronosyltransferase
genemissensealleleinChineseneonates.ActaPaediatr.2007Nov.96(11):16225.[Medline].
80.WatchkoJF.Vigintiphobiarevisited.Pediatrics.2005Jun.115(6):174753.[Medline].[FullText].
MedscapeReference2011WebMD,LLC
http://emedicine.medscape.com/article/974786clinical
5/5
